New York Stock Exchange Suspends Eve Holding Warrants After Price Falls to Unusually Low Levels
Key Facts
The New York Stock Exchange notified Eve Holding on October 21, 2026, that it would begin proceedings to delist its publicly traded warrants under ticker EVEXW and immediately suspend trading in them. The exchange publicly announced the decision on October 22, citing a decline in the selling price to “unusually low levels.” The action was taken under Section 802.01D of the Listed Company Manual. It applies to the warrants, which are separate instruments from the company’s common stock. The disclosure did not say that trading in the warrants had stopped across all markets or platforms.
The exchange cited a direct reason for the action: an unusually low selling price. Its disclosure did not link the move to a structural change at the company or a general failure to meet listing requirements. Section 802.01D, the provision cited by the NYSE, provides a basis for beginning delisting proceedings for warrants in light of that price level. This rationale distinguishes the exchange’s decision concerning a specific financial instrument from the status of the listed company as a whole. Eve Holding said in its disclosure that the decision to begin proceedings included an immediate suspension of trading in the warrants. Final delisting does not take effect merely because the procedural process has begun.
The decision applies only to the EVEXW warrants, while Eve Holding’s common stock continues to trade on the New York Stock Exchange under ticker EVEX. The company said trading in its common stock “will not be affected by the delisting of the warrants,” while remaining subject to the exchange’s other ongoing listing requirements. Thus, according to the disclosure, the common stock remains listed, while the warrants face a trading suspension and delisting proceedings. EVEX’s continued trading does not exempt the company from other requirements applicable to its stock listing. The announced action also does not cover the common stock itself.
Each EVEXW warrant entitles its holder to purchase one share of Eve Holding common stock at an exercise price of $11.50 per share. The company said each warrant is “currently exercisable for one share of the company’s common stock” at that price. These terms define the instrument targeted by the NYSE decision: a warrant providing the right to a share, not common stock or a public offering. The disclosure set May 9, 2027, as the warrants’ expiration date. That date establishes a deadline for the instrument, but does not change the fact that trading in it was immediately suspended on the New York Stock Exchange.
Eve Holding may still seek a review of the NYSE Regulation staff’s decision by a committee of the exchange’s board. The regulator said the company “has the right to request a review of this decision” by the committee, allowing it to challenge the action under the prescribed procedures. The announcement did not say whether the company would request a review or when a decision on such a request might be made. An appeal therefore remains a possible part of the process before a final delisting application. This follows the notice to the company on October 21 and the exchange’s announcement of the decision the next day.
After completing the relevant procedures, including any appeal by the company, the NYSE said it would apply to the U.S. Securities and Exchange Commission to delist the warrants. NYSE Regulation said the application would be filed “upon completion of all relevant procedures, including any appeal” of its staff’s decision. A possible review therefore precedes the exchange’s application to the agency for delisting. The announcement did not set a date for completing these steps or for an SEC decision. Chief Financial Officer Eduardo Seiffert Coto signed the company’s disclosure of the decision on October 26, 2026.